Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

Share Price is delayed by 15 minutes
Get Live Data
488.00    -12.00 (-2.40%)
Bid:
490.00
Ask:
495.00
Spread: 5.00 (1.02%)
Market Cap: £805.76m
OCI Live PriceLast checked at - London Stock Exchange

Intraday Oakley Share Chart

Acquisition of 7NXT

1 Oct 2020 07:00

RNS Number : 6906A
Oakley Capital Investments Limited
01 October 2020
 

01 October 2020

Oakley Capital Investments Limited

 

Acquisition of 7NXT, the German leader in online fitness and nutrition

 

Transaction: The Origin Fund has agreed to acquire a majority stake in 7NXT

Investment: The total equity investment from the Fund will be €42.6 million

 

Oakley Capital Investments Limited1 (the "Company" or "OCI") is pleased to announce that Oakley Capital Origin Fund ("Origin")2 has acquired a majority stake in 7NXT GmbH ("7NXT" or the "Group"), the leading online fitness and nutrition platform in the German speaking region, from founder and CEO Markan Karajica and Crosslantic Capital. Mr Karajica will continue in his role as CEO and will retain a significant minority stake in the business.

 

7NXT comprises three businesses: Gymondo, the leading female-focused online fitness subscription platform; Shape Republic, a direct-to-consumer fitness nutrition and supplements brand; and Brand Solutions, 7NXT's complementary merchandising and licensing division. Gymondo accounts for the majority of the Group's revenues, offering subscription-based access to high-quality workout videos, customised fitness programs and personalised nutrition plans. Since launching in 2013, Gymondo has seen over 2 million accounts registered.

Through its investment, Oakley will partner with Mr Karajica and the management team to scale 7NXT in the rapidly growing online fitness and health market and accelerate both its domestic and international growth. Oakley will support the management team through its network, operational experience and expertise in the consumer technology sector, established through its track record of successful investments in market leading platforms, such as Parship Elite, Facile.it and Wishcard Technologies Group (formerly Seven Miles).

Oakley originated the deal through a strong relationship with the founder Markan Karajica. The investment demonstrates Oakley's ability to leverage its wider network and its reputation as an attractive business partner for entrepreneurs.

The Origin Fund, to which OCI made an initial commitment in July 2020, has invested €42.6 million to acquire 7NXT.

Peter Dubens, Managing Partner of Oakley Capital, commented:

"7NXT is a leader in the high-growth digital fitness and nutrition market, with an excellent leadership team, driven to fulfil their mission of empowering people to live healthy and positive lifestyles. As a founder-led, tech-enabled business, 7NXT demonstrates many of the traits that Oakley targets in an investment and we believe that it is well placed to build on its position as the German market leader. We are looking forward to partnering with Markan and the team at this exciting stage."

Markan Karajica, CEO of 7NXT Group, commented:

"We are thrilled to have found an experienced and dynamic partner in Oakley, with a shared vision to accelerate the growth of the company in the coming years, both in Germany and internationally. My team and I look forward to taking 7NXT to the next level with Oakley's support."

 

- ends -

 

For further information please contact:

 

Oakley Capital Limited

+44 20 7766 6900

Steven Tredget, Investor Relations

 

Greenbrook Communications Limited

+44 20 7952 2000

Alex Jones / Gina Bell / James Williams

 

 

 

Liberum Capital Limited (Financial Adviser & Broker)

+44 20 3100 2000

Gillian Martin / Owen Matthews

 

Notes:

This announcement contains inside information for the purposes of the Market Abuse Regulation (EU) No. 596/2014

LEI Number: 213800KW6MZUK12CQ815

About Oakley Capital Investments Limited ("OCI")

OCI is a Specialist Fund Segment ("SFS") traded investment vehicle that aims to provide shareholders with consistent long-term capital growth in excess of the FTSE All-Share Index by providing liquid access to private equity returns through investment in the Oakley Funds2.

A video introduction to OCI is available at https://oakleycapitalinvestments.com/videos/

2Oakley Capital, the Investment Adviser

Founded in 2002, Oakley Capital Limited has demonstrated the repeated ability to source attractive growth assets at attractive prices. To do this it relies on its sector and regional expertise, its ability to tackle transaction complexity and its deal generating entrepreneur network.

The Oakley Funds

Oakley Capital Private Equity L.P. and its successor funds, Oakley Capital Private Equity II, Oakley Capital Private Equity III, Oakley Capital IV and Oakley Capital Origin Fund are unlisted lower-mid to mid-market private equity funds that aim to provide investors with significant long-term capital appreciation. The investment strategy of the Funds is to focus on buy-out opportunities in industries with the potential for growth, consolidation and performance improvement.

Important information

Specialist Fund Segment securities are not admitted to the Official List of the Financial Conduct Authority. Therefore, the Company has not been required to satisfy the eligibility criteria for admission to listing on the Official List and is not required to comply with the Financial Conduct Authority's Listing Rules.

The Specialist Fund Segment is intended for institutional, professional, professionally advised and knowledgeable investors who understand, or who have been advised of, the potential risk from investing in companies admitted to the Specialist Fund Segment.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQWPUMCBUPUGBU
Date   Source Headline
19th Jun 20267:01 amRNSTransaction in Own Shares
17th Jun 20267:00 amRNSTransaction in Own Shares
15th Jun 20267:00 amRNSTransaction in Own Shares
10th Jun 20267:00 amRNSTransaction in Own Shares
9th Jun 20267:00 amRNSTotal Voting Rights
3rd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20264:51 pmRNSResult of AGM
1st Jun 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSTransaction in Own Shares
26th May 20267:00 amRNSOakley Capital invests in XTEL
21st May 20267:00 amRNSTransaction in Own Shares
18th May 20267:00 amRNSTransaction in Own Shares
13th May 20267:00 amRNSTransaction in Own Shares
11th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSNotice of AGM
1st May 20267:00 amRNSTotal Voting Rights
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTrading update for the 3 months ended 31 March 26
24th Apr 20267:00 amRNSDirector Dealing
1st Apr 20267:00 amRNSTotal Voting Rights
31st Mar 20267:00 amRNSStandard form for notification of major holdings
17th Mar 20267:00 amRNSOakley Capital partners with Groupe Senef
17th Mar 20267:00 amRNSOakley Capital partners with Groupe Senef
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSFinal Results for the Year Ended 31 December 2025
12th Mar 20267:00 amRNSFinal Results for the Year Ended 31 December 2025
10th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSNotice of Results and Investor Presentation
3rd Mar 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSDirector Dealing
17th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 202612:05 pmRNS-RUpdate from QuotedData
11th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20263:26 pmRNSStandard form for notification of major holdings
6th Feb 20263:26 pmRNSStandard form for notification of major holdings
6th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20269:43 amRNS-RUpdate from QuotedData
4th Feb 20267:00 amRNSDirector Dealing
2nd Feb 20267:00 amRNSTotal Voting Rights
28th Jan 20267:00 amRNSTrading update for the year ended 31 December 2025
26th Jan 20267:00 amRNSStandard form for notification of major holdings
9th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20265:49 pmRNSStandard form for notification of major holdings
5th Jan 20267:00 amRNSOakley Capital invests in GLAS
5th Jan 20267:00 amRNSTotal Voting Rights
31st Dec 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.